#replicon

[thefreethoughtprojectcom]

Have you heard about the next generation of "vaccines" that Big Pharma is preparing to unleash upon the public? They're called sa-mRNA vaccines, or "replicon" vaccines, and they've already been approved in Japan.

Read More: https://thefreethoughtproject.com/vaccine-safety-health/replicon-big-pharma-preps-the-next-bioweapon

#TheFreeThoughtProject

[biglisbonnews]

Putting productivity in its rightful place in your company’s tech stack Enterprises across the globe have experienced common challenges as the pandemic effectively rewrote the rulebook, spurring widespread adoption of remote and hybrid working models and processes nearly overnight. Operationalizing that change was business-critical, but its impact continues to ripple outward.Read more... https://qz.com/putting-productivity-in-its-rightful-place-in-your-comp-1850233840

[iconsynth]

kagamine len reply iconz? /nf

(YOUR STUFF IS REALLY COOL BY THE WAY!!!)

Here you go! Sorry they took so long 😭

[didanawisgi]

Attack of the Replicons

The Biopharmaceutical Complex's self-amplifying mRNA assault has already begun.

NICOLAS HULSCHER, MPH

NOV 07, 2024

By Nicolas Hulscher, MPH

The Biopharmaceutical Complex is preparing for the large-scale deployment of replicon (self-amplifying) mRNA injections. There are currently at least 33 candidatesin development.

These products behave like a synthetic virus. The replicon mRNA is designed to encode not only the target antigen but also viral replicase, enabling the mRNA to replicate itself within the target cells. This replication machinery allows for an unknown period of toxic antigen production. Concerningly, none of the clinical trials have addressed the major concern of product shedding.

The Coalition for Epidemic Preparedness Innovations (CEPI) and the Biomedical Advanced Research and Development Authority (BARDA) are the primary funders behind this technology to combat ‘Disease X’. This is an extremely high risk ‘vaccine’ platform that should be avoided at all costs. Cellular installation of synthetic replicons requires decades of intense safety testing.

The very first replicon injection for human use received emergency use authorization (EUA) from The Office of the Drugs Controller General of India (DCGI) back in June 2022: Gennova Biopharmaceuticals’ GEMCOVAC-19. This was followed by reckless EUA approval in June 2023 for GEMCOVAC-OM, a replicon booster shot that targets the Omicron strain. 

In November 2023, Japan's Ministry of Health, Labor and Welfare (MHLW) fully approved CSL and Arcturus Therapeutics' replicon shot: KOSTAIVE ARCT-154. Dismissing all concerns, Japan’s MHLW approved the updated booster shot in��September 2024 to target the JN.1 lineage of Omicron subvariants.

In the clinical trials for ARCT-154, 5 deaths occurred among the injected in study phase 3b. Injected participants experienced a 90% adverse event rate (74.5% systemic - 15.2% required medical attention) after the first dose in study phases 1, 2, and 3a combined. Many of the authors are full time employees of Arcturus Therapeutics, meaning their conclusions are likely biased. 

Meanwhile, the USDA quietly approved an experimental self-amplifying RNA injection for dogs developed by Merck in June 2024: Nobivac NXT Canine Flu H3N2. It appears that Merck is attempting to camouflage the fact that this product is self-amplifying. The primary product description only indicates that it uses “revolutionary RNA particle technology.” However, the novel platform works by RNA particles targeting dendritic cells, where they self-replicate and result in sustained antigen production. 

The possibility of product shedding from dogs to humans or other animals was never tested. This injection is currently widely available for online purchase and canine administration. While the Biopharmaceutical Complex struggles to get self-amplifying mRNA injections approved for humans, they seem to have no problem targeting our pets.

Deployment of this experimental platform has continued in September 2024 to target cats: Nobivac NXT FeLV. Nowhere in the product brochure does it mention the RNA self-amplification mechanism of action. They hope that unsuspecting vets won't think twice about accepting the 'new and improved' product. The so-called 'safety' data for this product is as follows: 

“Demonstrated safety under field conditions" from "Data on file. Merck Animal Health." 

In other words, no public safety data is provided. It's become abundantly clear that the pharmaceutical industry and captured regulatory agencies have zero regard for the massive safety concerns of undefined synthetic mRNA replication resulting in uncontrolled toxic antigen production. These experimental injections must not receive further regulatory approval for humans or animals if we are to prevent another public health disaster. All self-amplifying mRNA injections currently available for humans and animals should be immediately withdrawn until comprehensive, long-term safety studies are conducted.

[neonscented]

Now that my excitement for the OMORI cafe has worn off, the designs for Mari and Omori specifically look kind of... strange? I'm not sure how else to describe it.

[ozedits]

Hi hi! Could I request some pastel blue Sayaka Miki icons? Thank you!!

sorry for the wait shes been posted !! love her & great request actually

[covid-safer-hotties]

Also preserved on our archive (Daily updates)

Meanwhile, covid deniers are in charge of both our major parties here in the states... I wish we could have some kind of simple, reality-based response to misinformation like this.

TOKYO -- A Japanese pharmaceutical firm has revealed that it is considering filing a lawsuit seeking damages from a lawmaker who has been critical about the company's new coronavirus vaccine, describing it as being "like a biological weapon" in a post on X (formerly Twitter).

The replicon vaccine, which is sold by Meiji Seika Pharma Co. under the product name "Kostaive," has been put into practical use in this fall's routine inoculations against COVID-19 for the first time. The distributor is considering demanding compensation from Kazuhiro Haraguchi, a House of Representatives member belonging to the main opposition Constitutional Democratic Party of Japan, claiming that he has defamed the company's reputation by repeatedly expressing disapproval of the drug without scientific evidence.

According to Meiji Seika Pharma and other sources, Haraguchi described the replicon vaccine, which is designed to replicate messenger RNA in cells, as being "like a biological weapon" in a post on his X account. The company sent him a written warning in early October. However, in his campaign bulletin for the Oct. 27 lower house election, Haraguchi wrote, "It is no exaggeration to say that we are being used as guinea pigs when an unknown vaccine is approved only for Japan."

In an opinion released on Oct. 31, Meiji Seika Pharma stated, "We believe that such remarks by a Diet member run the risk of disrupting the foundation of science communication, which is based on objectivity guaranteed by the national government's intervention in medicine and scientific nature, and that they pose a major problem with regard to public health."

The company says that the timing of the lawsuit is "under consideration."

The Mainichi Shimbun asked Haraguchi for comment, but had not received a response as of 5 p.m. on Nov. 1.

(Japanese original by Yoshimi Nakamura, Lifestyle, Science & Environment News Department)

[prieastful]

would you possibly be willing to do shadow milk cookie(from ckr) tumblr layout + replicons? (And maybe some other graphics? If not thats okay! Thank you so much for your time!

  ི۪۪† SHADOW MILK COOKIE LAYOUT + REPLYICONS ⠀ ᛝ

requested by ; anon

f2u, credit me for this if used webp version included

[sunkupng]

Fxck off replicons

My new best friends are kaomojis ¯\_(ツ)_/¯

[darkmaga-returns]

by Nicolas Hulscher, MPH

As the U.S. begins to escalate their response against H5N1 bird flu, we will likely see a push for more unsafe and ineffective countermeasures. The Biopharmaceutical Complex is currently preparing bird flu mRNA injections developed by Moderna, CEPI-funded H5N1 replicon (self-amplifying) shots, and Arcturus Therapeutics replicon ‘pandemic’ bird flu injections funded by BARDA and the Gates Foundation. Thus, it is of high priority to identify promising compounds with anti-avian influenza activity that don’t involve injection of modified genetic material.

A 2023 study revealed a comprehensive list of natural plants and bioactive compounds that have shown anti-avian influenza activity: A systemic review on medicinal plants and their bioactive constituents against avian influenza and further confirmation through in-silico analysis.

Methods: 33 plants and 4 natural compounds were identified and documented. Molecular docking was performed against the target viral protein neuraminidase (NA), with some plant based natural compounds and compared their results with standard drugs Oseltamivir and Zanamivir to obtain novel drug targets for influenza. Results: It was seen that most extracts exhibit their action by interacting with viral hemagglutinin or neuraminidase and inhibit viral entry or release from the host cell. Some plants also interacted with the viral RNA replication or by reducing proinflammatory cytokines. Ethanol was mostly used for extraction. Among all the plants Theobroma cacao, Capparis Sinaica Veil, Androgarphis paniculate, Thallasodendron cillatum, Sinularia candidula, Larcifomes officinalis, Lenzites betulina, Datronia molis, Trametes gibbose exhibited their activity with least concentration (below 10 μg/ ml). The docking results showed that some natural compounds (5,7- dimethoxyflavone, Aloe emodin, Anthocyanins, Quercetin, Hemanthamine, Lyocrine, Terpenoid EA showed satisfactory binding affinity and binding specificity with viral neuraminidase compared to the synthetic drugs.

[deertism]

Edit log! Changed theme , updated pinned ( + new tags , key included ) , added ask game to pinned & shoved a TON of stuff into drafts ( mostly stamps & emojies sorry ). I still have yet to update the themes of my rentries & retrospring , but I'll get around to it. I may make some replicons but I'm iffy on that.

[drblacula]

:3 < I’m gonna put a list of things I’m gonna do next weekend since I’m tired and stuff :

1 . Challe Fen Challe graphics

2 . Firefly graphics

3 . Aventio graphics

4 . layout 4 my edit blog ++ replicons !!!

[neonscented]

I have it in my bio, but I want to clarify that the Daphne (and Doughie) replicons I use are not made by me, and are from the REVERIE mod. If I go back to using Sunny replicons at some point, those are all from official art.

[reportsofawartime]

自粛マスク蛋白マン

@1A48wvlkQc6mVdR

·

13時間

これについてるクソノートが笑えるね。だって、プラセボもクソも、そもそも参加者はどっちも接種者だからね。感染しようがナニをしようが機序的にはいつ死んでもおかしくないのだから、どっちが死んだとかいうこと自体に意味はない。もう治験などできる状態ではない

アーロン大塚

@AaronOtsuka

フォロー

レプリコン臨床試験で５人死亡 ARCT-154 COVID-19 Replicon Vaccine(自己増幅型mRNA)試験データを公開しました。 第3b相試験で注射された患者のうち5人が死亡した。注射された参加者は、研究フェーズ1、2、および3aを組み合わせた最初の投与後に90%の有害事象率(74.5%全身-15.2%の医師の診察が必要)を経験しました。 著者の多くは、ワクチンメーカーであるArcturusRxの正社員です。したがって、研究の結���は偏っている可能性が高い。 ARCT-154は、日本ではすでに成人向けに承認されています。安全性データは、この新しい遺伝子技術が人間にとって安全ではないことを裏付けています。 .https://nature.com/articles/s41467-024-47905-1